Reports
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
Hydroxycarbamide capsules | For myeloproliferative disorders. ESCA under development |
||
Hyoscine hydrobromide 300microgram tablets | For hypersalivation caused by antipsychotics |
||
Hyoscine patch | Very high relative cost |
||
Hyoscine tablets | Specialist initiation only |
||
Ibandronic acid tablet | ESCA |
||
Ibuprofen suspension | If swallowing difficulties and paediatric use |
||
Icatibant (Firazyr®) | NHS England commissioned |
||
Ichthammol 1% w/w and zinc oxide 15% w/w in Yellow Soft Paraffin | Unlicensed special |
||
Idarubicin injection | For hospital use only |
||
Idarucizumab 2.5g/250ml solution for injection/infusion | When rapid reversal of Dabigatran anticoagulant effect is required |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- Next page
- Last page
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.